Bardoxolone (CDDO)
Bardoxolone (CDDO), acts by releasing Nrf2 from KEAP1,is a highly potent activator of Nrf2 that induce programmed cell death (apoptosis) in cancer cells.
| Trivial name | RTA 401 |
| Catalog Number | S6647 |
| CAS# | 218600-44-3 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/bardoxolone.html |
| Additional Information | https://file.selleck.cn/downloads/struct/bardoxolone-chemical-structure-s6647.gif |